Current trends in QSAR on NO donors and inhibitors of nitric oxide synthase (NOS)

Medicinal Research Reviews

Volumn 22, Issue 4, 2002, Pages 385-418

  Kontogiorgis, Christos A ^a   Hadjipavlou Litina, Dimitra ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Electronic factors; Lipophilicity; NO donors; NOS inhibitors; QSAR; Steric factors

Indexed keywords

AMIDOX; AMIDOXIME DERIVATIVE; AMINO ACID DERIVATIVE; ARGININE; CITRULLINE; FURAN DERIVATIVE; FUROXAN DERIVATIVE; IMIDAZOLE DERIVATIVE; N(G) NITROARGININE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; TETRAZOLE DERIVATIVE; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; DRUG MECHANISM; DRUG SPECIFICITY; ELECTROCHEMICAL ANALYSIS; ENZYME INHIBITION; HYDROPHOBICITY; INHIBITION KINETICS; MATHEMATICAL ANALYSIS; MOLECULAR INTERACTION; MOLECULAR MODEL; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

ENZYME INHIBITORS; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036277305     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.10012     Document Type: Review

References (94)

1. Heterocyclic NO prodrugs
2. The enzymology and manipulation of nitric oxide synthase
3. NO-donors: An emerging class of compounds in Medicinal Chemistry
4. NO news is good news
5. Nitric oxide: A new paradigm for second messengers
6. The arginine-nitric oxide pathway a target for new drugs
7. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions
8. Neuronal nitric oxide synthase, modular enzyme formed by convergent evolution: Structure studies of a cysteine thiolate-liganded heme protein that hydroxylates L-arginine to produce NO as a cellular signal
9. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
10. Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages
11. Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor
12. +2/calmodulin-independent diaphorase and reductase activities
13. Tetrahydrodiopterin inhibits monomerization and is consumed during catalysis in neuronal NO synthase
14. Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer
15. Arginine is a physiological precursor of endothelium-derived nitric oxide
16. Vascular endothelial cells synthesize nitric oxide from L-arginine
17. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
18. L-NG-(1-Imino-ethyl)lysine: A selective inhibitor of inducible nitric oxide synthase
19. Inhibitors of nitric oxide synthases
20. S-substituted isothioureas are potent inhibitors of nitric oxide biosynthesis in cartilage
21. The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischemia
22. Inhibition of inducible nitric oxide synthase ameriolates cerebral ischaemic damage
23. The nitric oxide and cGMP signal transuction system: Regulation and mechanisms of action
24. Intracellular cyclic GMP receptor proteins
25. Organic nitrate esters: Clinical use and mechanisms of actions
26. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase
27. Possible mechanisms of activation of soluble guanylate cyclase by organic nitrates
28. 2+ channel antagonist vasodilator activities
29. Biochemical characterization of a membrane-bound enzyme responsible for generating nitric oxide from nitroglycerin in vascular smooth muscle cells
30. Oxidation of deoxyhemerythrin to semi-methemerythrin by nitrite
31. - donation by S-nitrosothiols: Implications for regulation of physiologicalfunctions by S-nitrosylation and acceleration of disulfide formation
32. Photosensitized decomposition of S-nitrosothiols and 2-methyl-2-nitrosopropane. Possible use for site-directed nitric oxide production
33. The relaxant properties in guinea pig airways of S-nitrosothiols
34. + channels in vasodilation induced by nitroglycerine, acetylcholine and nitric oxide
35. Comparative pharmacology of analogues of S-nitroso-N-acetyl-DL-penicillamine on human platelets
36. Copper chelation-induced reduction of the biological activity of S-nitrosothiols
37. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects
38. Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators
39. Complexes of nitric oxide with nucleophiles as agents for the controlled biological release of nitric oxide: Hemodynamic effect in the rabbit
40. Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release
41. The furoxan system as a useful tool for balancing "hybrids" with mixed alpha 1-antagonist and NO-like vasodilator activities
42. Acceleration of nitric oxide (NO) release from FK409, a spontaneous NO releaser, in the presence of sulfhydryl-bearing compounds
43. Formation of nitric oxide by cytochrome P450-catalyzed oxidation of aromatic amidoximes
44. N-hydroxylation of the antiprotozoal drug pentamidine catalyzed by rabbit liver cytochrome P-450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Possible relationship to the biological oxidation of arginine to NG-hydroxyarginine, citrulline, and nitric oxide
45. On the mechanism of nitric oxide formation upon oxidative cleavage of C=N(OH) bonds by NO-synthases and cytochromes P450
46. New NO-donors with antithrombotic and vasodilating activities. I: 3-Arylalkyl-N-nitroso-5-sydnone imines
47. Derivatives of 1,2-diazetidine-1, 2-di-N-oxides-a new class of soluble guanylate activators with vasodilatory properties
48. A new class of soluble guanylate cyclase activators, generating nitric oxide
49. Kinetics of nitric oxide liberation by 3,4-dihydro-1,2-diazete 1,2-dioxides and their vasodilatory properties in vitro and in vivo
50. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXIX: Influence of the antithrombotic oligoamine RE 1492 on the storage of red blood cells, morphology, their potassium and ATP content, hemolysis and viability
51. Chemical oxidation of N-hydroxyguanidine compounds. Release of nitric oxide, nitroxyl and possible relationship to the mechanism of biological nitric oxide generation
52. The pharmacological activity of nitroxyl: A potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor
53. Substituent constants for correlation analysis in Chemistry and Biology
54. Exploring Qsar: Fundamentals and applications in chemistry and biology
55. Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages
56. Synthesis and pharmacological evaluation of some 8-cyanopyrido[3′,2′:4,5]thieno[3,2-d]triazine derivatives as inhibitors of nitric oxide and eicosanoid biosynthesis
57. Characterisation of furoxancarbonitriles as a new class of vasodilators
58. Thiol mediated generation of nitric oxide accounts for the vasodilator action of furoxans
59. Water soluble furoxan derivatives as NO prodrugs
60. On the mechanism of nitric oxide formation upon oxidative cleavage of C=N(OH) bonds by NO-synthases and cytochromes P450
61. New NO-donors with antithrombotic and vasodilating activities, part 15 nitrolic acids
62. Azide oximes and 1-hydroxytetrazoles
63. Amidoximes and their Prodrugs
64. Abstracts, 3rd Graduate Student Meeting 2001, February 23rd-25th, Frankfurt/Main, Germany
65. Arylazoamidoximes and 3 -Arylazo-1,2,4-oxadiazol-5ones
66. Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole phenylimidazoles
67. The dual mode of inhibition of calmodulin-dependent nitric-oxide synthase by antifungal imidazole agents
68. Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole
69. Interferon-gamma-inducible murine macrophage nitric oxide synthase: Studies on the mechanism of inhibition by imidazole agents
70. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: Antinociceptive and cardiovascular effects
71. Mechanism of the inhibition of neuronal nitric oxide synthase by 1-(2trifluoromethylphenyl) imidazole (TRIM)
72. N-substituted-imidazoles as inhibitors of nitric oxide synthase: A preliminary screening
73. N-Phenylamidines as selective inhibitors of human meuronal nitric oxide synthase: Structure-activity studies and demonstration of in vivo activity
74. Nitroaromatic amino acids as inhibitors of neuronal nitric oxide synthase
75. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase
76. Inhibition of neuronal nitric oxide synthase by 4-amino pteridine derivatives: Structure-activity relationship of antagonist of (6R)-5,6,7,8-tetrahydrobiopteria cofactor
77. Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity and struc pre for the general class of 9-anilinoacridine antitumor agents
78. Quantitative structure-activity relationships (QSAR) for O-anilinoacridines: A comparative analysis
79. Chemico-bioinformatics and QSAR: A review of QSAR lacking positive hydrophobic terms
80. Molecular graphics and QSAR in the study of enzyme-ligand interaction. On the definition of bioreceptors
81. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate